Jared Whitlock
Reporter
Phone: 858-634-4636 Extension: 3130
Recent Stories
Researchers Hunting For Existing Drugs to Repurpose in Fight Against COVID-19
Already Proven Drugs Could Be a Quicker Way to Treat Virus
FDA Opens Door for Virus Diagnostics
MEDICINE: Mesa Biotech Readies 30-Minute Test
Forge Eligible for up to $190M in Antibiotic Deal with Roche
San Diego-based Forge Therapeutics struck an agreement with Roche centering on Forge’s antibiotic for treatment-resistant infections.
Companies Scale Up Production of COVID-19 Tests
Medicine: FDA Relaxes Rules to Aid Efforts
Companies Push Production Of Coronavirus Tests
Medicine: FDA Relaxes Rules to Aid Efforts
Inovio Pharmaceuticals Expects Human Testing Of COVID-19 Vaccine and Device Next Month
Biotech: Gates Foundation Gives Company $5M
DermTech Raises $65M in Private Placement for Skin Cancer Test
Funds To Accelerate Commercialization of Flagship Test
Maravai LifeSciences Acquires MockV Solutions
San Diego’s Maravai LifeSciences has purchased MockV Solutions for undisclosed terms, it was announced March 17.
n-Lorem Foundation Lands $500,000 for Rare Disease Work
The n-Lorem Foundation — a Carlsbad nonprofit that formed to supply individualized therapies free of charge to patients with ultra-rare genetic diseases — has received a $500,000 pledge.
San Diego Biotechs Forge Ahead on Potential COVID-19 Vaccines
MEDICINE: Arcturus Receives $10M From Singapore Agency
Mesa Biotech Developing Rapid COVID-19 Test
Laboratory-Quality Results May Be Possible in 30 Minutes
Alphatec to Buy EOS Imaging in $121.9M Deal
If the Sale Goes Smoothly, It Should Close in Fourth Quarter
Mesa Biotech Developing Rapid COVID-19 Test
Mesa Biotech is developing a COVID-19 test that aims to tell if someone has the virus in 30 minutes, amid clamoring to get answers faster as the deadly strain spreads.
Co. to Use Body’s Innate Immune System Against Cancer
Primmune Therapeutics Raises $7 Million in Seed Round
PvP Deal Could Be Worth More Than $330M
ACQUISITION: Takeda Gets Drug to Possibly Treat Celiac Disease
Arcturus Lands up to $10M for Potential Coronavirus Vaccine
Arcturus said its vaccine could be effective at lower doses than other RNA-based medicines, reducing the time and cost to vaccinate large populations.
Forte Biosciences Gets Nasdaq Listing After Tocagen Merger
FDA Decision on Opioid Alternative Delayed; Genomics Co. Has Series A
Alphatec to Buy EOS Imaging in $121.9M Deal
Carlsbad-based Alphatec has agreed to acquire EOS Imaging in a $121.9 million deal.
Device Cos. Report Solid Earnings
MEDICINE: Dexcom ResMed Have Strong Q4 Revenue
Company Gets $1 Million From Gates Foundation for Tuberculosis Testing
Company Is Developing Portable System to Detect Tuberculosis
DTx Takes on Delivery of RNA Meds
Pharma: Co. Came Through S.D. Ecosystem, Raises $10.6 Million
Ligand Pharmaceuticals Purchase Of Icagen Brings Partnerships, Platform
Icagen Inc. Is ‘Cash-Flow Positive and Profitable Business’
Vividion Recruits Former Pfizer Exec For C-Suite
Company Is Targeting ‘Undruggable’ Proteins
Biological Dynamics Gets $1M from Gates Foundation for Tuberculosis Test
San Diego’s Biological Dynamics is set to receive a $1 million grant from the Bill & Melinda Gates Foundation to push forward its tuberculosis test.
Haynes and Kearns Join Board of Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute has made two additions to its board who are well known in San Diego’s education and health care circles: Karen Haynes and Donald Kearns.
Robotic Lab Is an Experiment Itself
BIOTECH: Aims Are Research, Relationships
La Jolla Laser Vision & Eye Center Acquired
Acuity Eye Group has purchased La Jolla Laser Vision & Eye Center for an undisclosed amount.
Vividion Therapeutics Lures Former Pfizer Executive
Vividion Therapeutics – a San Diego upstart that last year raised an $82 million financing round – has announced the hiring of a former Pfizer executive.
Illumina Adds Scott Gottlieb To Its Board
Former FDA Commissioner Left Post in April
Neurocrine Beats Analysts Forecast For Fourth Quarter
Marketing to Patients, Caregivers Proves Successful
ResMed’s Q2 Net Income Increased 29% to $160.6 Million
Masks And Accessories Segment Grew in High Teens
Carlsbad Nonprofit Awarded $450K Chan-Zuckerberg Grant
The Grant Will Support Research, Infrastructure Needs
Biotechs in San Diego Join Race to Combat Coronavirus
MEDICINE: Investor Interest Swirls around Companies
A crop of life sciences companies are rushing to combat the coronavirus outbreak, triggering big movements in their stocks and millions in grant funding.
Illumina Adds Former FDA Commissioner to Board
Illumina recently made a major addition to its board: Scott Gottlieb, the former commissioner of the U.S. Food and Drug Administration.
Histogen Gets Nasdaq Listing Via Merger With Conatus
All Stock Transaction Gives Histogen 74% of Shares
Gates Foundation Awards $50M to Scripps Research
The Bill & Melinda Gates Foundation has awarded $50 million to a division of Scripps Research to push forward potential therapies for tuberculosis and malaria.
Carlsbad Nonprofit Awarded $450K Chan-Zuckerberg Grant
The Association for Creatine Deficiencies was awarded a $450,000 grant to combat a trio of disorders that can cause intellectual delays.
MeBe to Open Autism and Special Needs Center in Kearny Mesa
San Diego company MeBe on Feb. 15 is slated to open a center catering to young adults and children with autism and special needs.
Histogen to Go Public Via Merger With Conatus
Conatus Pharmaceuticals has agreed to merge with another San Diego biotech, Histogen, it was announced Jan. 28.
Sorrento Therapeutics Passes on $1.17B Offer
PHARMA: Three Bids Made for Co. Working On Opioid Alternative
Illumina Announces Its Q4 Results
Illumina reported revenue of $953 million in fourth quarter revenue.
Biotech Awarded up to $9M to Develop Coronavirus Vaccine
Inovio Pharmaceuticals was recently awarded up to a $9 million grant to develop a vaccine against a strain of coronavirus that’s spreading in China and spurred screening at U.S. airports.
Illumina Reports 10% Revenue Increase in Q4
Illumina reported revenue of $953 million in fourth quarter revenue, a 10% year-over-year increase that also beat analyst expectations.
Tyra Biosciences Raises $50 Million In Cancer Fight
Co. Targets Cancers That Have Become Drug Resistant
Device Companies See Advantage In Partnering With Big Tech
From Hardware to Data, Verily Helping Local Companies Better Cater to Consumer Needs
ResMed Settles Kickback Allegations, Agrees to Pay $37.5M
ResMed will pay $37.5 million to settle allegations that the company paid kickbacks to suppliers, sleep labs and other health care providers, the Department of Justice recently announced.
Actor Gets Role at Scripps Bridging Communication Gap
Inovio Awarded $9M for Coronavirus Research
Tyra Biosciences Raises $50M to Take On Drug Resistant Cancers
Tyra Biosciences, a Carlsbad company that wants to combat cancers that become drug-resistant, has raised a $50 million round.
Cos. Find Deals, Dollars at J.P. Morgan
BIOTECH: HL Buys, Sells; New Partnership Unveiled for Illumina
Debut Looks to Move Drug Manufacturing Forward
San Diego-Based Co. Closes $2.6 Million Seed Round
Prev Next